Bioventus (BVS) EV to EBIT (2021 - 2026)

Bioventus (BVS) has reported EV to EBIT for 6 consecutive years, with 43.98 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBIT rose 42.51% year-over-year to 43.98; the trailing twelve-month figure through Jun 2026 stood at 14.43 (down 11.93% YoY), and the FY2025 full-year result was 11.3, up 120.14% from the prior year.
• EV to EBIT declined to 43.98 in Q2 2026 per BVS's latest filing, from 89.75 in the prior quarter.
• Across five years, EV to EBIT topped out at 366.68 in Q4 2023 and bottomed at 175.89 in Q3 2022.
• Historically, EV to EBIT has averaged 61.82 across 5 years, with a median of 40.35 in 2026.
• The sharpest annual moves came in 2022 and 2024: EV to EBIT slumped 238.35% in 2022, then soared 9279.0% in 2024.
• Over 5 years, EV to EBIT stood at 16.62 in 2022, then jumped by 2305.59% to 366.68 in 2023, then plunged by 69.82% to 110.65 in 2024, then sank by 71.72% to 31.29 in 2025, then surged by 40.54% to 43.98 in 2026.
• According to Business Quant data, EV to EBIT over the past three periods registered 43.98, 89.75, and 31.29 for Q2 2026, Q1 2026, and Q4 2025 respectively.